5 things about AI you might have missed today: EU AI law facing opposition, Microsoft’s new AI course, etc.

Today is a big day in the world of artificial intelligence. As the European Union begins finalizing the rewritten AI laws, many companies have begun to share concerns and call on the EU to review the policies. In other news, Microsoft has launched a new AI skills initiative, a free course, globally, through which it intends to help people understand the potential uses of AI. This and more in today’s AI compendium. Let’s take a closer look.

Top companies issue warnings about EU AI laws

Many major business leaders are opposing the EU’s proposed AI law, arguing that it limits competitiveness and could harm the development of this new technology and drive investors away. Europe.

In an open letter to the EU, there are hundreds of signatories including executives from companies such as Siemens, Renault and Airbus as well as prominent individuals such as Meta’s chief AI scientist, Yann LeCun. The UK’s ARM chipmaker founder Hermann Hauser said: “In our judgment, the draft law will jeopardize Europe’s competitiveness and technological sovereignty if it is not effectively addressed. challenges that we are and will have to face.”

“Such regulation could lead to highly innovative companies moving their operations abroad. The result will be a severe productivity gap between the two sides of the Atlantic,” it added.

Microsoft launches new AI initiative

Microsoft, on Friday, announced a new AI Skills Initiative to help people and communities around the world learn to harness the power of AI. This includes a free course that has been developed with LinkedIn.

In its statement, Microsoft highlights a statistic taken from the company’s Job Trends Index that mentions that up to 74% of Indians raise a fear that AI will replace their jobs. job.

“Ultimately, the Microsoft AI Skills Initiative will aim to help workers overcome emerging skills gaps and reduce digital debt – the constant volume of data, information, and communication. – and unleashes creativity,” parcel mentioned.

AI-generated drugs enter clinical trials

Earlier this year, Insilico Medicine, a biotech startup based in Hong Kong, created the first drug entirely powered by AI. The drug INS018_055 for the treatment of idiopathic pulmonary fibrosis, a chronic lung disease, has now entered human trials.

“This is the first fully artificial intelligence drug to be clinically tested in humans, specifically in a phase II trial with patients. While there are other AI-designed drugs being tested, our drug is the first to have both a new AI-detected target and a new AI-generated design,” said Alex Zhavoronkov, who Founder and CEO of Insilico Medicine. speak CNBC.

Inflection AI raises $1.3 billion from investors including billionaire And Nvidia

Inflection AI, the startup that gained attention for building a “kind and supportive” AI chatbot called Pi, has now raised a whopping $1.3 billion. This marked one of the largest funding rounds of Silicon Valley in the field of AI.

The startup is less than two years old and was co-founded by LinkedIn co-founder Reid Hoffman, and Mustafa Suleyman, one of Google’s DeepMind founders.

This investment round is led by Microsoft’s Bill Gates, Nvidia, former Google CEOs Eric Schmidt and Hoffman. The startup is being considered a competitor of OpenAI.

Fake AI Cryptocurrency Ads Show Celebrities Like Bear Grylls, Ian Wright

According to one report by The Standard, scammers are using AI tools to create fake cryptocurrency ads and run them on Facebook and Twitter. These ads show celebrities such as former Arsenal football player Ian Wright, adventurer Bear Grylls, celebrity chef Gino D’Acampo and others. According to reports, the ad was seen on Twitter more than a million times.

These ads are being distributed by scammers to endorse a product, spread fake news or lure victims to fake websites.